Cancer BioBank is a next-generation biobank dedicated to the collection, processing, cryopreservation, and molecular profiling of tumor tissues and blood-derived samples to advance personalized oncology. Each sample is paired with rich pre-analytical, clinical, and research metadata, enabling studies on disease evolution, therapy response, and chemoresistance prediction.

This biobank provides high-quality biospecimens and data to hospitals, researchers, and pharmaceutical companies, accelerating biomarker discovery, diagnostic validation, and clinical innovation. With GDPR-compliant Dynamic Consent from Metabio, donors maintain transparent and ongoing control over how their samples are used.

The result is a trusted, tamper-traceable, and clinically relevant biobank that addresses critical gaps in Southeast Europe and beyond, advancing precision diagnostics, guiding treatment selection, and strengthening the oncology research ecosystem.

The next generation of connected health solutions calls for a unified biomedical IoT platform that enables remote patient monitoring across web and mobile, seamlessly integrating with medical devices, environmental sensors, and fitness trackers. By leveraging IoT data, it can optimize treatment adherence, deliver personalized digital services for chronic conditions and older adults, and provide behavioral monitoring to identify at-risk patients through event analysis. Advanced features like context-aware medical visualization, decision support systems, and blockchain-powered security ensure reliability, privacy, and actionable insights for truly modern, distributed healthcare.